How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology

N. A. Fineberg; M. Van Ameringen; L. Drummond; E. Hollander; D. J. Stein; D. Geller; S. Walitza; S. Pallanti; L. Pellegrini; J. Zohar; C. I. Rodriguez; J. M. Menchon; P. Morgado; D. Mpavaenda; L. F. Fontenelle; J. D. Feusner; G. Grassi; C. Lochner; D. J. Veltman; N. Sireau; L. Carmi; D. Adam; H. Nicolini; B. Dell'Osso

doi:10.1016/j.comppsych.2020.152174

How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology

N. A. Fineberg^*
, M. Van Ameringen
, L. Drummond
, E. Hollander
, D. J. Stein
, D. Geller
, S. Walitza
, S. Pallanti
, L. Pellegrini
, J. Zohar
, C. I. Rodriguez
, J. M. Menchon
, P. Morgado
, D. Mpavaenda
, L. F. Fontenelle
, J. D. Feusner
, G. Grassi
, C. Lochner
, D. J. Veltman
, N. Sireau

L. Carmi, D. Adam, H. Nicolini, B. Dell'Osso

^*Corresponding author for this work

Clinical Departments

University of Hertfordshire
Hertfordshire Partnership University NHS Foundation Trust
University of Cambridge
McMaster University
Hamilton Health Sciences
St. George's University of London
Albert Einstein College of Medicine
University of Cape Town
Harvard University
University of Zurich
University of Florence
University of Bologna
Sheba Medical Center at Tel Hashomer
Stanford University
Department of Veterans Affairs
Hospital Universitari de Bellvitge
University of Minho
Hospital de Braga
Monash University
Universidade Federal do Rio de Janeiro
University of California at Los Angeles
Brain Center Firenze
SA MRC Unit on Risk and Resilience in Mental Disorders
Vrije Universiteit (VU) and VU Medical Centre
Orchard
Independent researcher
Instituto Nacional de Medicina Genomica
Carracci Medical Group
University of Milan

Research output: Contribution to journal › Article › peer-review

141 Scopus citations

Original language	English
Article number	152174
Journal	Comprehensive Psychiatry
Volume	100
DOIs	https://doi.org/10.1016/j.comppsych.2020.152174
State	Published - Jul 2020

Funding

Funders	Funder number
Biohaven Inc.
Rugen Therapeutics
U.S. Department of Defense
National Institute of Mental Health	R21 NCTID NCT03669315
BlackThorn Therapeutics
Instituto D'or de Pesquisa e Ensino
European Cooperation in Science and Technology	CA16207
Conselho Nacional de Desenvolvimento Científico e Tecnológico	302526/2018-8
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro	CNE E-26/203.052/2017
European College of Neuropsychopharmacology
Servier
H. Lundbeck A/S

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.comppsych.2020.152174

Cite this

Fineberg, N. A., Van Ameringen, M., Drummond, L., Hollander, E., Stein, D. J., Geller, D., Walitza, S., Pallanti, S., Pellegrini, L., Zohar, J., Rodriguez, C. I., Menchon, J. M., Morgado, P., Mpavaenda, D., Fontenelle, L. F., Feusner, J. D., Grassi, G., Lochner, C., Veltman, D. J., ... Dell'Osso, B. (2020). How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology. Comprehensive Psychiatry, 100, Article 152174. https://doi.org/10.1016/j.comppsych.2020.152174

Fineberg, N. A. ; Van Ameringen, M. ; Drummond, L. et al. / How to manage obsessive-compulsive disorder (OCD) under COVID-19 : A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology. In: Comprehensive Psychiatry. 2020 ; Vol. 100.

@article{ccc7267171d44a55a5fe580e2f3d4d16,

title = "How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology",

author = "Fineberg, \{N. A.\} and \{Van Ameringen\}, M. and L. Drummond and E. Hollander and Stein, \{D. J.\} and D. Geller and S. Walitza and S. Pallanti and L. Pellegrini and J. Zohar and Rodriguez, \{C. I.\} and Menchon, \{J. M.\} and P. Morgado and D. Mpavaenda and Fontenelle, \{L. F.\} and Feusner, \{J. D.\} and G. Grassi and C. Lochner and Veltman, \{D. J.\} and N. Sireau and L. Carmi and D. Adam and H. Nicolini and B. Dell'Osso",

note = "Funding Information: LFF was supported by Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico (CNPq; grant \# 302526/2018-8 , Rio de Janeiro, RJ, Brazil), Funda{\c c}{\~a}o de Amparo {\`a} Pesquisa do Estado do Rio de Janeiro (FAPERJ; grant \# CNE E-26/203.052/2017 , Rio de Janeiro, RJ, Brazil), the David Winston Turner Endowment Fund (Melbourne, VIC, Australia), and intramural grants from D'Or Institute for Research and Education (IDOR, Rio de Janeiro, RJ, Brazil). Funding Information: CIR has served as a consultant for Allergan, BlackThorn Therapeutics, Rugen Therapeutics, and Epiodyne, receives research grant support from Biohaven Inc. , and a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry. Funding Information: SP declares funding from the National Institute of Mental Health , USA; R21 NCTID NCT03669315 . Funding Information: The authors wish to acknowledge the International College of Obsessive Compulsive Spectrum Disorders ( www.ICOCS.org ), the European College of Neuropsychopharmacology (ECNP) Obsessive-Compulsive and Related Disorders Research Network (OCRN) and the COST Action CA16207 “European Network for Problematic Usage of the Internet”, supported by COST (European Cooperation in Science and Technology) ( www.cost.eu ), who have contributed, through providing networking opportunities, to the development of this guideline. Funding Information: JZ received grants and research support from Lundbeck , Servier , Brainsway , Pfizer \& the DOD , honoraria and consultation fees from Lundbeck, Roche, Lilly, Servier, Pfizer. ",

year = "2020",

month = jul,

doi = "10.1016/j.comppsych.2020.152174",

language = "אנגלית",

volume = "100",

journal = "Comprehensive Psychiatry",

issn = "0010-440X",

publisher = "W.B. Saunders",

}

Fineberg, NA, Van Ameringen, M, Drummond, L, Hollander, E, Stein, DJ, Geller, D, Walitza, S, Pallanti, S, Pellegrini, L, Zohar, J, Rodriguez, CI, Menchon, JM, Morgado, P, Mpavaenda, D, Fontenelle, LF, Feusner, JD, Grassi, G, Lochner, C, Veltman, DJ, Sireau, N, Carmi, L, Adam, D, Nicolini, H & Dell'Osso, B 2020, 'How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology', Comprehensive Psychiatry, vol. 100, 152174. https://doi.org/10.1016/j.comppsych.2020.152174

How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology. / Fineberg, N. A.; Van Ameringen, M.; Drummond, L. et al.
In: Comprehensive Psychiatry, Vol. 100, 152174, 07.2020.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - How to manage obsessive-compulsive disorder (OCD) under COVID-19

T2 - A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology

AU - Fineberg, N. A.

AU - Van Ameringen, M.

AU - Drummond, L.

AU - Hollander, E.

AU - Stein, D. J.

AU - Geller, D.

AU - Walitza, S.

AU - Pallanti, S.

AU - Pellegrini, L.

AU - Zohar, J.

AU - Rodriguez, C. I.

AU - Menchon, J. M.

AU - Morgado, P.

AU - Mpavaenda, D.

AU - Fontenelle, L. F.

AU - Feusner, J. D.

AU - Grassi, G.

AU - Lochner, C.

AU - Veltman, D. J.

AU - Sireau, N.

AU - Carmi, L.

AU - Adam, D.

AU - Nicolini, H.

AU - Dell'Osso, B.

N1 - Funding Information: LFF was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq; grant # 302526/2018-8 , Rio de Janeiro, RJ, Brazil), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ; grant # CNE E-26/203.052/2017 , Rio de Janeiro, RJ, Brazil), the David Winston Turner Endowment Fund (Melbourne, VIC, Australia), and intramural grants from D'Or Institute for Research and Education (IDOR, Rio de Janeiro, RJ, Brazil). Funding Information: CIR has served as a consultant for Allergan, BlackThorn Therapeutics, Rugen Therapeutics, and Epiodyne, receives research grant support from Biohaven Inc. , and a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry. Funding Information: SP declares funding from the National Institute of Mental Health , USA; R21 NCTID NCT03669315 . Funding Information: The authors wish to acknowledge the International College of Obsessive Compulsive Spectrum Disorders ( www.ICOCS.org ), the European College of Neuropsychopharmacology (ECNP) Obsessive-Compulsive and Related Disorders Research Network (OCRN) and the COST Action CA16207 “European Network for Problematic Usage of the Internet”, supported by COST (European Cooperation in Science and Technology) ( www.cost.eu ), who have contributed, through providing networking opportunities, to the development of this guideline. Funding Information: JZ received grants and research support from Lundbeck , Servier , Brainsway , Pfizer & the DOD , honoraria and consultation fees from Lundbeck, Roche, Lilly, Servier, Pfizer.

PY - 2020/7

Y1 - 2020/7

UR - https://www.scopus.com/pages/publications/85085592954

U2 - 10.1016/j.comppsych.2020.152174

DO - 10.1016/j.comppsych.2020.152174

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 32388123

AN - SCOPUS:85085592954

SN - 0010-440X

VL - 100

JO - Comprehensive Psychiatry

JF - Comprehensive Psychiatry

M1 - 152174

ER -

Fineberg NA, Van Ameringen M, Drummond L, Hollander E, Stein DJ, Geller D et al. How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology. Comprehensive Psychiatry. 2020 Jul;100:152174. doi: 10.1016/j.comppsych.2020.152174

How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology

Funding

UN SDGs

Access to Document

Other files and links

Cite this